No Data
No Data
Eli Lilly and Co (LLY.US) weight loss drug Mounjaro has been approved in Hong Kong and will be available for sale as early as the end of this year.
eli lilly and co is expected to start selling its popular weight loss drug in Hong Kong as early as the end of this year.
Benzinga Bulls And Bears: Nvidia, Tesla, MicroStrategy, Plug Power — And Crypto Traders Anticipate Dogecoin Topping 50 Cents
Heard on the Street: Pfizer's Activist Battle Might Fizzle -- but Its Stock Probably Won't -- WSJ
Top Gap Ups and Downs on Thursday: WST, TSLA, IBM and More
Ozempic Can Potentially Cut Risk Of Alzheimer's Compared To Other Diabetic Medicines, Study Shows
Novo Nordisk's Semaglutide Could Also Be Effective Against Alzheimer's